(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 48.59%-455.34K | -455.78%-77.46K | -126.01%-873.51K | -143.80%-458.84K | -70.43%449.29K | -263.69%-885.73K | -91.32%21.77K | 1,409.51%3.36M | 96.49%1.05M | 1,025.53%1.52M |
Net income from continuing operations | 94.28%-81.3K | 43.53%363.34K | -191.45%-2.94M | -630.23%-1.31M | -125.57%-462.01K | -314.87%-1.42M | -49.73%253.15K | -73.25%3.22M | -67.58%247.77K | -85.97%1.81M |
Operating gains losses | -142.39%-48.85K | -30.55%-138.43K | 104.53%15.16K | 78.92%114.59K | 61.96%-108.64K | 178.04%115.25K | -404.23%-106.04K | 97.54%-334.37K | 220.74%64.04K | 97.91%-285.59K |
Depreciation and amortization | -41.60%37.58K | -24.60%48.44K | 12.86%257.32K | 2.13%64.37K | 10.80%64.37K | 16.66%64.34K | 24.17%64.24K | 9.36%228.01K | 13.29%63.02K | 9.32%58.09K |
Asset impairment expenditure | -29.31%37.06K | -62.31%48.84K | 732.31%1M | 278.51%65.88K | 1,321.74%754.87K | 762.41%52.43K | 195.19%129.6K | -77.90%120.48K | 169.42%17.4K | -85.83%53.1K |
Unrealized gains and losses of investment securities | -70.66%63.1K | 178.41%136.63K | -87.09%97.95K | -41.43%47.92K | -97.04%9.23K | -17.16%215.06K | -265.49%-174.25K | 143.81%758.69K | 120.73%81.82K | -11.66%311.97K |
Remuneration paid in stock | --0 | --0 | 1,307.63%788.27K | --330.02K | --88.86K | 533.69%323.18K | 824.00%46.2K | -90.90%56K | --0 | --0 |
Deferred tax | ---- | ---- | -112.35%-24.59K | ---- | ---- | ---- | ---- | 114.93%199.16K | ---- | ---- |
Other non cashItems | -620.09%-365.65K | 8.49%-410.26K | -218.99%-898.34K | -30.09%-496.4K | -110.48%-23.93K | -52.89%70.31K | -61.46%-448.32K | -107.19%-281.62K | -50.45%-381.58K | 1,447.00%228.37K |
Change In working capital | 68.00%-97.28K | -149.00%-126.03K | 237.09%832.85K | -0.37%753.11K | 119.37%126.54K | 38.49%-303.99K | 219.16%257.2K | -509.64%-607.52K | 385.38%755.93K | -225.33%-653.37K |
-Change in receivables | 61.88%-59.4K | -73.80%75.11K | 485.97%692.5K | -69.40%370.06K | 118.03%191.62K | -328.76%-155.84K | 397.65%286.66K | 174.16%118.18K | 344.11%1.21M | -453.24%-1.06M |
-Change in payables and accrued expense | 74.44%-37.87K | -582.74%-201.13K | 119.34%140.36K | 184.49%383.06K | -115.89%-65.09K | 73.65%-148.16K | 75.36%-29.46K | -335.87%-725.69K | -288.96%-453.39K | 4,806.29%409.59K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 48.59%-455.34K | -455.78%-77.46K | -126.01%-873.51K | -143.80%-458.84K | -70.43%449.29K | -263.69%-885.73K | -91.32%21.77K | 1,409.51%3.36M | 96.49%1.05M | 1,025.53%1.52M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 29.39%-264.54K | -88.05%-543.79K | 42.08%-1.26M | 63.37%-264.88K | 49.96%-327.7K | 33.56%-374.63K | -27.25%-289.18K | -118.40%-2.17M | -392.22%-723.19K | -105.35%-654.89K |
Net PPE purchase and sale | 28.03%-250.8K | --0 | 40.98%-1.26M | 31.10%-1.25M | --0 | 38.19%-348.47K | 98.24%-4.01K | -120.38%-2.13M | -1,134.39%-1.81M | 69.51%-153.97K |
Net other investing changes | 47.45%-13.74K | -90.69%-543.79K | 100.86%342 | -9.69%984.76K | 34.58%-327.7K | ---26.15K | ---285.18K | ---40K | --1.09M | ---500.92K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 29.39%-264.54K | -88.05%-543.79K | 42.08%-1.26M | 63.37%-264.88K | 49.96%-327.7K | 33.56%-374.63K | -27.25%-289.18K | -118.40%-2.17M | -392.22%-723.19K | -105.35%-654.89K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | -312.32%-41.75K | 0 | 0 | -978.88%-41.75K | -10.13K | -14.88K | 0 | ||
Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --4.75K | --0 | --0 |
Net other financing activities | ---- | ---- | -180.65%-41.75K | --0 | ---- | ---41.75K | ---- | ---14.88K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | -312.32%-41.75K | --0 | --0 | -978.88%-41.75K | --0 | ---10.13K | ---14.88K | --0 |
Net cash flow | ||||||||||
Beginning cash position | -13.93%15.6M | -11.80%16.22M | 6.85%18.4M | -6.29%16.95M | -2.30%16.83M | 5.16%18.13M | 6.85%18.4M | 230.84%17.22M | 7.47%18.09M | 261.93%17.22M |
Current changes in cash | 44.71%-719.88K | -132.32%-621.25K | -284.09%-2.17M | -333.83%-723.72K | -85.94%121.6K | -7,150.02%-1.3M | -1,235.35%-267.41K | -90.18%1.18M | -19.86%309.5K | -92.84%864.6K |
End cash Position | -11.55%14.88M | -13.93%15.6M | -11.80%16.22M | -11.80%16.22M | -6.29%16.95M | -2.30%16.83M | 5.16%18.13M | 6.85%18.4M | 6.85%18.4M | 7.47%18.09M |
Free cash from | 40.12%-739.02K | -535.98%-77.46K | -279.91%-2.13M | -123.02%-1.71M | -67.10%449.29K | -3,908.46%-1.23M | 225.54%17.77K | 257.01%1.18M | -298.35%-766.07K | 304.09%1.37M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data